-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Aytu Biopharma, Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2014 to 2024.
- Aytu Biopharma, Inc Amortization of Intangible Assets for the quarter ending June 30, 2024 was $1.3M, a 9.04% increase year-over-year.
- Aytu Biopharma, Inc Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $5.21M, a 8.86% increase year-over-year.
- Aytu Biopharma, Inc annual Amortization of Intangible Assets for 2024 was $5.21M, a 8.86% increase from 2023.
- Aytu Biopharma, Inc annual Amortization of Intangible Assets for 2023 was $4.79M, a 18.1% decline from 2022.
- Aytu Biopharma, Inc annual Amortization of Intangible Assets for 2022 was $5.84M, a 2.75% decline from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)